ResearcherFujian Medical UniversityNo recent work listed
Xiong Chen
Matched on ORCID iD 0000-0001-5316-6512; OpenAlex author ID A5100770688. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper
Papers 5
- BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. Co-author DOI 10.5301/ijbm.5000310↗
- Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1177/1010428317699131↗
- Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-4675-5↗
- Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. Co-author DOI 10.1155/2016/8137378↗
- CacyBP/SIP protein promotes proliferation and G1/S transition of human pancreatic cancer cells. Co-author DOI 10.1002/mc.20737↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xuenong Ouyang · 4 shared papers, 2016–2018 · strength 0.26
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Jiawei Zheng · 4 shared papers, 2016–2018 · strength 0.26
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Shanshan Huang · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Yu-Fang Huang · 3 shared papers, 2016–2018 · strength 0.20
- Paper BTG1 low expression in pancreatic ductal adenocarcinoma is associated with a poorer prognosis. DOI 10.5301/ijbm.5000310↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Paper Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. DOI 10.1155/2016/8137378↗
- Yin Yin · 3 shared papers, 2016–2017 · strength 0.19
- Paper Expression and clinical significance of placenta-specific 1 in pancreatic ductal adenocarcinoma. DOI 10.1177/1010428317699131↗
- Paper Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma. DOI 10.1007/s13277-015-4675-5↗
- Paper Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-Analysis. DOI 10.1155/2016/8137378↗
- Yan Zhang · 1 shared paper, 2017 · strength 0.06
- Song Li · 1 shared paper, 2016 · strength 0.06
- Shanshan Huang · 1 shared paper, 2016 · strength 0.06
- Daiming Fan · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.